{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:13:07Z","timestamp":1794960787781,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["111565741641"],"award-info":[{"award-number":["111565741641"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Many gaps in the burden of resistant pathogens exist in endemic areas of low- and middle-income economies, especially those endemic for carbapenem resistance. The aim of this study is to evaluate risk factors for carbapenem-resistance, to estimate the association between carbapenem-resistance and all-cause 30-day mortality and to examine whether mortality is mediated by inappropriate therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A case-control and a cohort study were conducted in one tertiary-care hospital in Medell\u00edn, Colombia from 2014 to 2015. Phenotypic and genotypic characterization of isolates was performed. In the case-control study, cases were defined as patients infected with carbapenem-resistant<jats:italic>K. pneumoniae<\/jats:italic>(CRKP) and controls as patients infected with carbapenem-susceptible<jats:italic>K. pneumoniae<\/jats:italic>(CSKP). A risk factor analysis was conducted using logistic regression models. In the cohort study, the exposed group was defined as patients infected with CRKP and the non-exposed group as patients infected with CSKP. A survival analysis using an accelerated failure time model with a lognormal distribution was performed to estimate the association between carbapenem resistance and all-cause 30-day-mortality and to examine whether mortality is mediated by inappropriate therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 338 patients were enrolled; 49 were infected with CRKP and 289 with CSKP. Among CRKP isolates CG258 (<jats:italic>n<\/jats:italic>\u2009=\u200929), ST25 (<jats:italic>n<\/jats:italic>\u2009=\u20095) and ST307 (<jats:italic>n<\/jats:italic>\u2009=\u20094) were detected. Of importance, every day of meropenem (OR 1.18, 95%CI 1.10\u20131.28) and cefepime (OR 1.22, 95%CI 1.03\u20131.49) use increase the risk of carbapenem resistance. Additional risk factors were previous use of ciprofloxacin (OR 2.37, 95%CI 1.00\u20135.35) and urinary catheter (OR 2.60, 95%CI 1.25\u20135.37). Furthermore, a significant lower survival time was estimated for patients infected with CRKP compared to CSKP (Relative Times 0.44, 95%CI 0.24\u20130.82). The strength of association was reduced when appropriate therapy was included in the model (RT\u2009=\u20090.81 95%CI 0.48\u20131.37).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Short antibiotic courses had the potential to reduce the selection and transmission of CRKP. A high burden in mortality occurred in patients infected with CRKP in a KPC endemic setting and CRKP leads to increased mortality via inappropriate antibiotic treatment. Furthermore, dissemination of recognized hypervirulent clones could add to the list of challenges for antibiotic resistance control.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-019-4461-x","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T12:02:54Z","timestamp":1570449774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3407-6463","authenticated-orcid":false,"given":"Astrid V.","family":"Cienfuegos-Gallet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Ocampo de Los R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Sierra Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiver","family":"Ramirez Brinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Restrepo Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Roncancio Villamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"del Corral Londo\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Natalia","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"4461_CR1","volume-title":"Platform for health information in the Americas [Plataforma de informaci\u00f3n de salud en las Am\u00e9ricas]","author":"Panamerican Health Organization","year":"2013","unstructured":"Panamerican Health Organization. Platform for health information in the Americas [Plataforma de informaci\u00f3n de salud en las Am\u00e9ricas] 2013. http:\/\/www.paho.org\/data\/index.php\/es\/temas\/resistencia-antimicrobiana\/323-klebsiella-spp-es.html . Accessed 23 May 2018."},{"key":"4461_CR2","doi-asserted-by":"publisher","unstructured":"Llewelyn MJ, Fitzpatrick JM, Darwin E, Tonkin-Crine S, Gorton C, Paul J, et al. The antibiotic course has had its day. Br Med J. 2017;358. https:\/\/doi.org\/10.1038\/sj.bdj.2017.760 .","DOI":"10.1038\/sj.bdj.2017.760"},{"issue":"10","key":"4461_CR3","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.ajic.2019.03.020","volume":"47","author":"Suluck Soontaros","year":"2019","unstructured":"Soontaros S, Leelakanok N. Association between carbapenem-resistant Enterobacteriaceae and death: a systematic review and meta-analysis. Am J Infect Control. 2019;0. https:\/\/doi.org\/10.1016\/j.ajic.2019.03.020 .","journal-title":"American Journal of Infection Control"},{"key":"4461_CR4","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s10096-017-3010-z","volume":"36","author":"DR Giacobbe","year":"2017","unstructured":"Giacobbe DR, Maraolo AE, Viscoli C. Pitfalls of defining combination therapy for carbapenem-resistant Enterobacteriaceae in observational studies. Eur J Clin Microbiol Infect Dis. 2017;36:1707\u20139. https:\/\/doi.org\/10.1007\/s10096-017-3010-z .","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4461_CR5","volume-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Antimicrobial resistance: global report on surveillance. 2014."},{"key":"4461_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price LS, Poirel L, R a B, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785\u201396. https:\/\/doi.org\/10.1016\/S1473-3099(13)70190-7 .","journal-title":"Lancet Infect Dis"},{"key":"4461_CR7","volume-title":"Results from the antimicrobial resistance surveillance program in healthcare associated infections 2015. [Resultados del Programa de Vigilancia por Laboratorio de Resistencia antimicrobiana en Infecciones Asociadas a la Atenci\u00f3n en Salud (IAAS) 2015]","author":"Instituto Nacional de Salud","year":"2015","unstructured":"Instituto Nacional de Salud. Results from the antimicrobial resistance surveillance program in healthcare associated infections 2015. [Resultados del Programa de Vigilancia por Laboratorio de Resistencia antimicrobiana en Infecciones Asociadas a la Atenci\u00f3n en Salud (IAAS) 2015]. 2015."},{"key":"4461_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1128\/AAC.01775-15.Address","volume":"60","author":"AM Ocampo","year":"2016","unstructured":"Ocampo AM, Chen L, Cienfuegos AV, Roncancio G, Chavda KD, Kreiswirth BN. A two-year surveillance in five Colombian tertiary care hospitals reveals high frequency of non-CG258 clones of Carbapenem- resistant Klebsiella pneumoniae with. Distinct Clin Charact. 2016;60:332\u201342. https:\/\/doi.org\/10.1128\/AAC.01775-15.Address .","journal-title":"Distinct Clin Charact"},{"issue":"5","key":"4461_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"Teresa C. Horan","year":"2008","unstructured":"CDC - Center for Disease Control and Prevention, National Healthcare Safety Network. CDC \/ NHSN surveillance definitions for specific types of infections. CDC\/NHSN Surveill Defin Specif Types Infect. 2014:1\u201324. https:\/\/doi.org\/10.1016\/j.ajic.2008.03.002 .","journal-title":"American Journal of Infection Control"},{"key":"4461_CR10","doi-asserted-by":"publisher","DOI":"10.1198\/jasa.2006.s89","volume-title":"Handbook of Epidemiology","author":"J Cavanaugh","year":"2006","unstructured":"Cavanaugh J. Handbook of Epidemiology, vol. 101; 2006. https:\/\/doi.org\/10.1198\/jasa.2006.s89 ."},{"key":"4461_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/21505594.2016.1213473","volume":"8","author":"SR Evans","year":"2017","unstructured":"Evans SR, Harris AD. Methods and issues in studies of CRE. Virulence. 2017;8:453\u20139. https:\/\/doi.org\/10.1080\/21505594.2016.1213473 .","journal-title":"Virulence"},{"key":"4461_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales K, MacKenzie R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"4461_CR13","volume-title":"M100-S24 performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement","author":"Clinical and Laboratory Standards Institutes","year":"2014","unstructured":"Clinical and Laboratory Standards Institutes. M100-S24 performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. 2014."},{"key":"4461_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1128\/JCM.01588-10","volume":"49","author":"L Chen","year":"2011","unstructured":"Chen L, Mediavilla JR, Endimiani A, Rosenthal ME, Zhao Y, R a B, et al. Multiplex real-time PCR assay for detection and classification of Klebsiella pneumoniae carbapenemase gene (Bla KPC) variants. J Clin Microbiol. 2011;49:579\u201385. https:\/\/doi.org\/10.1128\/JCM.01588-10 .","journal-title":"J Clin Microbiol"},{"key":"4461_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70:119\u201323. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2010.12.002 .","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4461_CR16","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1128\/AAC.00316-12","volume":"56","author":"L Chen","year":"2012","unstructured":"Chen L, Chavda KD, Mediavilla JR, Zhao Y, Fraimow HS, Jenkins SG, et al. Multiplex real-time PCR for detection of an epidemic KPC- producing Klebsiella pneumoniae ST258 clone. Antimicrob Agents Chemother. 2012;56:3444\u20137. https:\/\/doi.org\/10.1128\/AAC.00316-12 .","journal-title":"Antimicrob Agents Chemother"},{"key":"4461_CR17","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1128\/AAC.00120-14","volume":"58","author":"L Chen","year":"2014","unstructured":"Chen L, Chavda KD, Melano RG, Jacobs MR, Koll B, Hong T, et al. Comparative genomic analysis of KPC-encoding pKpQIL-like plasmids and their distribution in New Jersey and New York hospitals. Antimicrob Agents Chemother. 2014;58:2871\u20137. https:\/\/doi.org\/10.1128\/AAC.00120-14 .","journal-title":"Antimicrob Agents Chemother"},{"key":"4461_CR18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7883\/yoken.JJID.2009.372","volume":"62","author":"R Durmaz","year":"2009","unstructured":"Durmaz R, Otlu B, Koksal F, Hosoglu S, Ozturk R, Ersoy Y, et al. The optimization of a rapid pulsed-field gel electrophoresis protocol for the typing of Acinetobacter baumannii, Escherichia coli and Klebsiella spp. Jpn J Infect Dis. 2009;62:372\u20137.","journal-title":"Jpn J Infect Dis"},{"key":"4461_CR19","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1128\/JCM.43.8.4178","volume":"43","author":"L Diancourt","year":"2005","unstructured":"Diancourt L, Passet V, Verhoef J, Patrick a D, Grimont P a D, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43:4178\u201382. https:\/\/doi.org\/10.1128\/JCM.43.8.4178 .","journal-title":"J Clin Microbiol"},{"key":"4461_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/9781118548387","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2013","unstructured":"Hosmer DW, Lemeshow SSR. Applied logistic regression. 3rd ed. Hoboken: Wiley; 2013. https:\/\/doi.org\/10.1002\/9781118548387 .","edition":"3"},{"key":"4461_CR21","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1002\/sim.2836","volume":"26","author":"C Cox","year":"2007","unstructured":"Cox C, Chu H, Schneider MF, Mu\u00f1oz A. Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Stat Med. 2007;26:4352\u201374. https:\/\/doi.org\/10.1002\/sim.2836 .","journal-title":"Stat Med"},{"key":"4461_CR22","volume-title":"RStudio: integrated development for R","author":"RStudio Team","year":"2015","unstructured":"RStudio Team. RStudio: integrated development for R. Boston: RStudio, Inc.; 2015. n.d. http:\/\/www.rstudio.com"},{"key":"4461_CR23","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1128\/AAC.01020-07","volume":"52","author":"MJ Schwaber","year":"2008","unstructured":"Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition anions hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52:1028\u201333. https:\/\/doi.org\/10.1128\/AAC.01020-07 .","journal-title":"Antimicrob Agents Chemother"},{"key":"4461_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/ice.2017.62","volume":"2015","author":"K Okamoto","year":"2017","unstructured":"Okamoto K, Lin MY, Haverkate M, Lolans K, Moore NM, Weiner S, et al. Modifiable risk factors for the spread of Klebsiella pneumoniae Carbapenemase-producing Enterobacteriaceae among long-term acute-care hospital patients for the CDC Prevention Epicenters Program. Infect Control Hosp Epidemiol. 2017;2015:1\u20138. https:\/\/doi.org\/10.1017\/ice.2017.62 .","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4461_CR25","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/jac\/dkm356","volume":"60","author":"ME Falagas","year":"2007","unstructured":"Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case - control study. J Antimicrob Chemother. 2007;60:1124\u201330. https:\/\/doi.org\/10.1093\/jac\/dkm356 .","journal-title":"J Antimicrob Chemother"},{"key":"4461_CR26","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1086\/598244","volume":"30","author":"K Hussein","year":"2009","unstructured":"Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol. 2009;30:666\u201371. https:\/\/doi.org\/10.1086\/598244 .","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4461_CR27","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1086\/648451.Risk","volume":"30","author":"LB Gasink","year":"2009","unstructured":"Gasink LB, Edelstein P, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemas-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009;30:1180\u20135. https:\/\/doi.org\/10.1086\/648451.Risk .","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4461_CR28","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1086\/671270","volume":"34","author":"M Swaminathan","year":"2013","unstructured":"Swaminathan M, Sharma S, Poliansky Blash S, Patel G, Banach DB, Phillips M, et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol. 2013;34:809\u201317. https:\/\/doi.org\/10.1086\/671270 .","journal-title":"Infect Control Hosp Epidemiol"},{"key":"4461_CR29","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/jac\/dkr116","volume":"66","author":"EI Kritsotakis","year":"2011","unstructured":"Kritsotakis EI, Tsioutis C, Roumbelaki M, Christidou A, Gikas A. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Chemother. 2011;66:1383\u201391. https:\/\/doi.org\/10.1093\/jac\/dkr116 .","journal-title":"J Antimicrob Chemother"},{"key":"4461_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/AAC.50.1.43","volume":"50","author":"V Aloush","year":"2006","unstructured":"Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa : risk factors and clinical impact. Antimicrob Agents Chemother. 2006;50:43\u20138. https:\/\/doi.org\/10.1128\/AAC.50.1.43 .","journal-title":"Antimicrob Agents Chemother"},{"key":"4461_CR31","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1128\/JCM.00088-14","volume":"52","author":"LN Andrade","year":"2014","unstructured":"Andrade LN, Vitali L, Gaspar GG, Bellissimo-Rodrigues F, Martinez R, Darini ALC. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J Clin Microbiol. 2014;52:2530\u20135. https:\/\/doi.org\/10.1128\/JCM.00088-14 .","journal-title":"J Clin Microbiol"},{"key":"4461_CR32","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1099\/jmm.0.000254","volume":"65","author":"E da Silva","year":"2016","unstructured":"da Silva E, Maciel G, Correia F, Carvalhaes C, Rodrigues-Costa F, Ramos A, et al. Risk factors for KPC-producing Klebsiella pneumoniae: watch out for surgery. J Med Microbiol. 2016;65:547\u201353. https:\/\/doi.org\/10.1099\/jmm.0.000254 .","journal-title":"J Med Microbiol"},{"key":"4461_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2334-13-80","volume":"13","author":"L Correa","year":"2013","unstructured":"Correa L, Martino MDV, Siqueira I, Pasternak J, Gales AC, Silva CV, et al. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis. 2013;13:80\u20138. https:\/\/doi.org\/10.1186\/1471-2334-13-80 .","journal-title":"BMC Infect Dis"},{"key":"4461_CR34","doi-asserted-by":"publisher","unstructured":"Tian L, Tan R, Chen Y, Sun J, Liu J, Qu H, et al. Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital : factors related to the carbapenem resistance and patient mortality. Antimicrob Resist Infect Control. 2016. https:\/\/doi.org\/10.1186\/s13756-016-0145-0 .","DOI":"10.1186\/s13756-016-0145-0"},{"key":"4461_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s15010-012-0354-2","volume":"41","author":"GB Orsi","year":"2013","unstructured":"Orsi GB, Bencardino A, Vena A, Carattoli A, Venditti C, Falcone M, et al. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study. Infection. 2013;41:61\u20137. https:\/\/doi.org\/10.1007\/s15010-012-0354-2 .","journal-title":"Infection"},{"key":"4461_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jhin.2012.10.012","volume":"83","author":"K Hussein","year":"2013","unstructured":"Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I, et al. Impact of carbapenem resistance on the outcome of patients\u2019 hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect. 2013;83:307\u201313. https:\/\/doi.org\/10.1016\/j.jhin.2012.10.012 .","journal-title":"J Hosp Infect"},{"key":"4461_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","volume":"16","author":"L Xu","year":"2017","unstructured":"Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16:18\u201330. https:\/\/doi.org\/10.1186\/s12941-017-0191-3 .","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"11","key":"4461_CR38","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1017\/ice.2017.197","volume":"38","author":"Philipp P. Kohler","year":"2017","unstructured":"Kohler PP, Volling C, Green K, Uleryk EM, Shah PS, McGeer A. Carbapenem resistance, initial antibiotic therapy, and mortality in Klebsiella pneumoniae bacteremia: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2017:1\u201310. https:\/\/doi.org\/10.1017\/ice.2017.197 .","journal-title":"Infection Control & Hospital Epidemiology"},{"key":"4461_CR39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/cc5019","volume":"10","author":"MJ Schwaber","year":"2006","unstructured":"Schwaber MJ, Carmeli Y. Antimicrobial resistance and patient outcomes: the hazards of adjustment. Crit Care. 2006;10:164. https:\/\/doi.org\/10.1186\/cc5019 .","journal-title":"Crit Care"},{"key":"4461_CR40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","author":"American Thoracic Society, Infectious Diseases Society of America","year":"2005","unstructured":"American Thoracic Society, Infectious Diseases Society of America. Guidelines for the Management of Adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388\u2013416. https:\/\/doi.org\/10.1164\/rccm.200405-644ST .","journal-title":"Am J Respir Crit Care Med"},{"key":"4461_CR41","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63:e61\u2013111. https:\/\/doi.org\/10.1093\/cid\/ciw353 .","journal-title":"Clin Infect Dis"},{"issue":"1","key":"4461_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1128\/AAC.01775-15","volume":"60","author":"Ana M. Ocampo","year":"2015","unstructured":"Ocampo AM, Chen L, Cienfuegos AV, Roncancio G, Chavda KD, Kreiswirth BN, et al. A two-year surveillance in five Colombian tertiary care hospitals reveals high frequency of non-CG258 clones of carbapenem-resistant Klebsiella pneumoniae with distinct clinical characteristics. Antimicrob Agents Chemother. 2016;60. https:\/\/doi.org\/10.1128\/AAC.01775-15 .","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"4461_CR43","doi-asserted-by":"publisher","first-page":"e0132936","DOI":"10.1371\/journal.pone.0132936.","volume":"10","author":"C Bonura","year":"2015","unstructured":"Bonura C, Giuffr\u00e8 M, Aleo A, Fasciana T, Di Bernardo F, Stampone T, et al. An update of the evolving epidemic of blaKPC carrying Klebsiella pneumoniae in Sicily, Italy, 2014: emergence of multiple non-ST258 clones. PLoS One. 2015;10:e0132936. https:\/\/doi.org\/10.1371\/journal.pone.0132936.","journal-title":"PLoS One"},{"key":"4461_CR44","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cmi.2015.09.025","volume":"22","author":"M Cubero","year":"2016","unstructured":"Cubero M, Grau I, Tubau F, Pallar\u00e9s R, Dominguez MA, Li\u00f1ares J, et al. Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007-2013). Clin Microbiol Infect. 2016;22:154\u201360. https:\/\/doi.org\/10.1016\/j.cmi.2015.09.025 .","journal-title":"Clin Microbiol Infect"},{"key":"4461_CR45","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1086\/340533","volume":"34","author":"AD Harris","year":"2002","unstructured":"Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli. Clin Infect Dis. 2002;34:1558\u201363. https:\/\/doi.org\/10.1086\/340533 .","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4461-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4461-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4461-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T10:27:34Z","timestamp":1695292054000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4461-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4461"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4461-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,7]]},"assertion":[{"value":"11 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Bioethics Committee for Human Research at the University of Antioquia (CBE-SIU) and the hospital\u2019s research ethics committee approved the study protocol and waived the requirement for informed consent (approval of CBE-SIU No. 14\u2013355-72).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"830"}}